It is the first and, so far, only treatment indicated for the reduction of excess abdominal fat in patients with HIV-associated lipodystrophy
Antibiotic therapy resulted in augmented osteogenesis and improved characteristics of bone mass and increased overall mechanical resistance
Obstet Gynecol 2014;124:763-70
More research is needed, but the findings suggest that semaglutide and, perhaps other GLP-1 agonists, hold promise for helping people with MASH and highlight yet another potential benefit from this type of drug
While the FDA does not have a specific GLP-1 friendly claim standard yet, brands are using language like high protein, small portions, nutrient-dense snack, and designed for mindful eating to signal relevance to this consumer segment